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Abstract
SHARPIN is a ubiquitin-binding and ubiquitin-like domain-containing protein which, when
mutated in mice, results in immune system disorders and multiorgan inflammation1,2. Here we
report that SHARPIN functions as a novel component of the Linear Ubiquitin Chain Assembly
Complex (LUBAC) and that the absence of SHARPIN causes disregulation of NF-κB and
apoptotic signalling pathways, explaining the severe phenotypes displayed by chronic proliferative
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dermatitis in SHARPIN deficient mice. Upon binding to the LUBAC subunit HOIP, SHARPIN
stimulates the formation of linear ubiquitin chains in vitro and in vivo. Co-expression of
SHARPIN and HOIP promotes linear ubiquitylation of NEMO, an adaptor of the IκB kinases
(IKKs) and subsequent activation of NF-κB signalling, while SHARPIN deficiency in mice causes
an impaired activation of the IKK complex and NF-κB in B cells, macrophages, and mouse
embryonic fibroblasts (MEFs). This effect is further enhanced upon concurrent downregulation of
HOIL-1L, another HOIP-binding component of LUBAC. In addition, SHARPIN deficiency leads
to rapid cell death upon TNFα stimulation via FADD- and Caspase-8-dependent pathways.
SHARPIN thus activates NF-κB and inhibits apoptosis via distinct pathways in vivo.
In addition to the established roles of K63- and K48-linked ubiquitin chains, linear ubiquitin
chains have recently emerged as important regulators of the NF-κB pathway, controlling
immune responses, as well as cell survival, proliferation, and development3,4,5,6,7,8. Linear
ubiquitin conjugation relies on two RING-between-RING (RBR) domain-containing
proteins, HOIL-1L (longer isoform of hem-oxidized iron-regulatory protein 2 ubiquitin
ligase-1) and HOIP (HOIL-1L interacting protein), which together form the E3 ligase
complex LUBAC (linear ubiquitin chain assembly complex)9. We became interested in
SHARPIN (SHANK-associated RH domain-interacting protein) because of the significant
sequence homology of its C-terminal region, enclosing a ubiquitin-like (UBL) domain and a
putative ubiquitin-binding NPL4 zinc finger domain (NZF), with the N-terminal region of
HOIL-1L9,10 (Fig. 1a). Initially, we established SHARPIN as a bona fide ubiquitin binding
protein by mapping the ubiquitin binding site to the NZF domain (Supplementary Fig. 1). A
direct NZF-dependent interaction of SHARPIN with mono-ubiquitin, linear, and K63
ubiquitin chains was confirmed by pull-down assays (Supplementary Fig. 1b–d) and
isothermal titration calorimetry (ITC) (Fig. 1b). Mutagenesis of two key residues
surrounding the zinc coordination site of the NZF (T358L, F359V) abolished ubiquitin
binding (Supplementary Fig. 1a and 1c). The isolated NZFs of SHARPIN, HOIL-1L, and
HOIP interact with monoubiquitin with similar affinities (Fig. 1b), recognizing the classical
hydrophobic patch surrounding I44, as indicated by the absence of any interaction with
mutant I44A ubiquitin (Fig. 1b) and display no specificity for different chain types (Fig. 1b
and Supplementary Fig. 1c). These data are consistent with binding assays employing a
panel of HOIP and HOIL-1L protein variants expressed in transfected cells or in in vitro
ubiquitin binding experiments (Supplementary Fig. 1e–h).
We next investigated whether SHARPIN directly associates with the LUBAC complex in
cells. Tagged versions of HOIP, HOIL-1L, and SHARPIN were readily immunoprecipitated
from lysates of transiently transfected HEK293T cells (Fig. 1c). Likewise, the interaction of
endogenous SHARPIN, HOIP, and HOIL-1L was confirmed in primary mouse embryonic
fibroblasts (MEFs) (Fig. 1d). The interaction between SHARPIN and HOIP is mediated by
the UBL domain of SHARPIN, which recognizes the NZF2 domain of HOIP
(Supplementary Fig. 1i and j). In agreement, the interaction between HOIP and SHARPIN
was abolished in response to either deletion or mutation (I272A) of the UBL domain of
SHARPIN, but was not affected in the ubiquitin-binding deficient mutant of SHARPIN NZF
(Supplementary Fig. 2a). On the other hand, purified HOIL-1L did not interact with full-
length SHARPIN in in vitro binding assays (Supplementary Fig. 2b). Thus, HOIP has the
capacity to interact with either SHARPIN or HOIL-1L or both of them. Indeed, endogenous
HOIP can form a complex with only HOIL-1L or SHARPIN in the absence of the other,
since in SHARPIN or HOIL-1 deficient MEFs, HOIP can co-precipitate with residual
HOIL-1L or SHARPIN, respectively (Fig. 1d). Interestingly, the deficiency of either
SHARPIN or HOIL-1L led to a partial destabilization of the other protein (Fig. 1d).
Together these findings indicate the existence of three putative LUBAC complexes: dimeric
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complexes, HOIP-HOIL-1L (LUBAC-I) and HOIP-SHARPIN (LUBAC-II), and a trimeric
SHARPIN-HOIP-HOIL-1L complex (Supplementary Fig. 2c).
The purified HOIP-SHARPIN complex stimulated the in vitro assembly of linear ubiquitin
chains (Fig. 2a), similar to the ligase activity of a HOIP-HOIL-1L complex (Supplementary
Fig. 3a). We thus extended our studies to investigate whether SHARPIN and HOIP can
induce linear ubiquitylation of proteins in cells. The UBAN domain of ABIN-1, known to
preferentially bind linear ubiquitin chains11,12, was used as an affinity matrix to pull down
cellular proteins modified by linear ubiquitylation upon overexpression of SHARPIN and
HOIP (Fig. 2b and Supplementary Fig. 3f). Both the NZF and UBL domains of SHARPIN,
were essential for this activity, since neither the SHARPIN-NZF (T358L, F359V), nor the
SHARPIN-UBL (I272A) mutant showed any ability to induce linear ubiquitylation in vivo
(Fig. 2b). Similarly, the ABIN1-UBAN D485A mutant, which is unable to bind linear
polyubiquitin, did not pull down any ubiquitin conjugates (Fig. 2b, Supplementary Fig. 3d–
e). A specific enrichment of linear ubiquitylation in cells overexpressing SHARPIN and
HOIP was further confirmed by MS/MS analysis. In samples transfected with HOIP-
SHARPIN as well as HOIP-HOIL-1L the linear ubiquitin peptide GGMQIFVK was
detected (Fig. 2c). MS-based quantification (employing the AQUA approach described in
Supplementary Fig. 4a) detected an increase in the absolute amounts of ubiquitin present in
linear chains compared to the total pool of ubiquitin (measured by the
TITLEVEPSDTIENVK peptide) in cells expressing wild type HOIP-SHARPIN, in contrast
to cells expressing an inactive HOIP-SHARPIN complex (Supplementary Fig. 4b–e). We
next performed a SILAC-based quantitative MS/MS analysis on immunoprecipitated NEMO
upon co-transfection with either wild type or inactive HOIP-SHARPIN (experimental design
is shown in Supplementary Fig. 5a and b). The measured intensity of linear ubiquitin
peptides on immunoprecipitated NEMO was >25 times higher in cells transfected with wild
type HOIP-SHARPIN as compared to cells expressing inactive HOIP-SHARPIN mutants
(Fig. 2d and e). In the same sample we detected 13 ubiquitylation sites on NEMO, of which
11 were increased following transfection with wild type versus mutated HOIP-SHARPIN
(Supplementary Fig. 5c), suggesting that NEMO is a substrate of LUBAC II.
SHARPIN deficient (Sharpincpdm/Sharpincpdm) mice exhibit diverse phenotypes in the
immune system, which resemble the phenotypes of genetically engineered mouse models
with impaired NF-κB activation7,8. As linear ubiquitylation is important for activation of the
NF-κB pathway3,11,13,14 we speculated that the HOIP-SHARPIN LUBAC complex might
play a critical role in regulation of the NF-κB pathway. Consistent with this hypothesis,
cotransfection of SHARPIN and HOIP increased transcription of a luciferase-based NF-κB
reporter, similar to the effect of HOIP and HOIL-1L co-expression (Fig. 2f), while no
activation of NF-κB was detected when cells were transfected with SHARPIN, HOIL-1L, or
HOIP alone (Fig. 2f), or a combination of mutant forms of NZF or UBL domains in
SHARPIN together with HOIP (Fig. 2g).
Based on the finding that TNFα stimulated formation of a signalling complex between
HOIP-SHARPIN and NEMO (Supplementary Fig. 6), we reasoned that the SHARPIN-
HOIP complex might act as an upstream regulator of IKK activation. In vitro IKK kinase
assay showed that TNFα rapidly enhanced IKK kinase activity in wild type MEFs, which
was delayed and reduced in cells lacking SHARPIN (Fig. 3a). Upon additional abrogation of
HOIL-1L expression in Sharpincpdm/Sharpincpdm MEFs by stably expressing shRNA against
HOIL-1L (Sharpincpdm/Sharpincpdm shHOIL-1L) IKK activation was further inhibited (Fig.
3a). Moreover, downstream events of IKK activation, such as phosphorylation and
subsequent degradation of IκBα, as well as nuclear translocation of p65, were also reduced
in Sharpincpdm/Sharpincpdm MEFs and further impaired in response to shRNA-mediated
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downregulation of HOIL-1L (Fig. 3b, 3c and Supplementary Fig. 7a) or overexpression of
an IκBα-super repressor mutant (Supplementary Fig. 7b).
Given the plethora of evidence presented above that SHARPIN modulates the NF-κB
pathway, we further assessed the functional role of SHARPIN in NF-κB activation in vivo
using cells isolated from the Sharpincpdm/Sharpincpdm mice. The absence of SHARPIN in
Sharpincpdm/Sharpincpdm splenic B-cells stimulated with soluble CD40L resulted in
impaired activation of the NF-κB pathway, evaluated by phosphorylation and degradation of
IκBα, compared to wild type B-cells (Fig. 3d). Similar findings were obtained in
thioglycollate-induced peritoneal macrophages from Sharpincpdm/Sharpincpdm mice, which
in response to bacterial lipopolysacharide (LPS) stimulation failed to induce an efficient
phosphorylation and degradation of IκBα (Fig. 3e), proper nuclear translocation of the NF-
κB transcription factor p65 (Supplementary Fig. 8a) or secretion of TNFα and MCP-1 (Fig.
3f and g). Furthermore, IL-1β stimulation-induced NF-κB activation was delayed in
SHARPIN deficient MEFs (Supplementary Fig. 8b). Similarly, we observed partial
impairment of JNK activation in response to TNFα, CD40L, or LPS in Sharpincpdm/
Sharpincpdm MEFs, B-cells, or macrophages, respectively, compared to wild type cells (Fig.
3e and Supplementary Fig. 8c–e).
An interesting feature of Sharpincpdm/Sharpincpdm mice is the combination of epidermal
hyperplasia and inflammation with the presence of apoptotic bodies in keratinocytes and
increased cell death in the skin15. Moreover, inhibition of TNFα-induced NF-κB signalling
in keratinocytes results in inflammatory skin lesions as observed in genetically engineered
mouse models, as well as in human diseases such as incontinentia pigmenti7. Using highly
sensitive impedance based real-time cell analyzer, we found that Sharpincpdm/Sharpincpdm
MEFs were extremely sensitive to rapid TNFα-induced cell death (Fig. 4a). This correlated
with an appearance of typical apoptotic cell morphology (Supplementary Fig. 9a) and early
signs (2–4 hours post TNFα stimulation) of apoptotic signalling, including proteolytic
cleavage of the initiator caspase, caspase-8, the effector caspase, caspase-3, as well as
PARP, a substrate of caspase-3 (Fig. 4b). In agreement with a requirement for caspase
activity for the induction of apoptosis, pre-treatment of Sharpincpdm/Sharpincpdm cells with
the general caspase inhibitor zVAD-FMK abolished the observed cell death in response to
TNFα (Supplementary Fig. 9b). When performing the reciprocal experiments on MEFs
derived from HOIL-1 null mice14, we observed a delayed and significantly weaker induction
of the apoptotic response in cells stimulated with TNFα and cycloheximide (CHX) (Fig. 4a).
In accordance, we were unable to detect rapid activation of caspase-3 and caspase-8 upon
TNFα or TNFα + CHX treatment of HOIL-1L deficient MEFs (Supplementary Fig. 9c).
Moreover, additional downregulation of HOIL-1L in Sharpincpdm/Sharpincpdm MEFs did
not further increase TNFα-induced apoptosis or caspase activation (Supplementary Fig. 9d),
whereas a combined lack of SHARPIN and HOIL-1L had a strong additive effect on the
inhibition of the NF-κB pathway (Fig. 3a–c). Cell death in Sharpincpdm/Sharpincpdm MEFs
was not upregulated by other stress stimuli, including Staurosporin, Brefeldin A, and
Doxrubicin (Supplementary Fig. 9e–g).
TNFα-induced cell death is known to proceed through the cytosolic TNFR1 signalling
complex II that is composed of TRADD, TRAF2, RIP1, caspase-8/10, and the death domain
containing protein FADD, which together serve as a cell death checkpoint control in TNF-
sensitive cells16,17. The apoptotic cell death displayed by Sharpincpdm/Sharpincpdm MEFs
occurs through the FADD and caspase-8-containing TNFR1 complex II, since retroviral
transduction of either a dominant negative mutant of FADD or CrmA, a cowpox virus
derived serine protease inhibitor (serpin) of caspase-8, markedly inhibited TNFα-induced
cell death (Fig. 4c and 4d). Importantly, we have also detected activation of caspase-3, -8,
and -9 in skin keratinocytes of Sharpincpdm/Sharpincpdm mice (Fig. 4e). Taken together, our
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results suggest that loss of SHARPIN expression sensitizes cells for TNFα-induced cell
death, in part dependent on a caspase-8 pathway. This phenomenon might be an underlying
mechanism for the development of inflammatory skin lesions in Sharpincpdm/Sharpincpdm
mice.
In conclusion, this study provides physiological evidence for a novel LUBAC complex
composed of HOIP, the major catalytic subunit, and the adaptor protein SHARPIN.
Together, SHARPIN and HOIP mediate linear ubiquitylation of NEMO in vivo (Fig. 2a–e,
Supplementary Fig. 4, 5) and activate the NF-κB pathway following overexpression in cells
(Fig. 2f, g). The interaction between multiple ubiquitylated NEMO molecules, via their
UBAN domains, may cause conformational changes promoting the activation of IKK
kinases11. In such a model, the dynamics of NF-κB activation in response to different
stimuli may be determined by the distinct ability of NEMO to recognize a variety of
ubiquitin signals, including different linkages (linear, K63 and K11)4,6,18 and varying
lengths of ubiquitin chains19. SHARPIN and HOIL-1L have overlapping roles in the
function of LUBAC as a key activator of the IKK complex and NF-κB signalling
downstream of several physiological stimuli (Fig. 3). On the other hand, SHARPIN, but not
HOIL-1L, deficiency in mice results in an increased cell death that is dependent on caspase-
mediated apoptosis, evident in MEFs and inflammatory skin lesions (Fig. 4). Given the
identified anti-apoptotic function of SHARPIN, this study exposes a putative role for linear
ubiquitylation in the regulation of cell death and strongly reinforces its impact on NF-κB
signalling and immune responses.
Methods Summary
Protein purification, apoptosis and biochemical assays
Recombinant proteins were expressed in Rosetta cells (Novagen). Detailed descriptions of
immunoprecipitation, immunoblotting, GST pull-downs and apoptotic assays are available
as Supplementary Information. ITC measurements were performed using a VP-ITC or
ITC200 (GE Healthcare), as described in Supplementary Methods.
Mice and isolation of primary cells
C57BNL/KaLawRij-Sharpincpdm/RijSunJ mice (JR7599, The Jackson Laboratory) were
raised in a pathogen-free environment. Resting mature B cells were isolated using negative
selection by CD43-coated magnetic beads (MiltenyiBiotec), thioglycollate-induced
macrophages were harvested from the peritoneal cavity and MEFs were immortalized using
SV40 large T-antigen transfection and dilution passaging.
Apoptosis assays—Quantitative apoptosis assays were performed in real time using a
noninvasive impedance based real-time cell analyzer (Roche).
Full Methods and any associated references are available in the supplementary online
material of the paper.
Methods
cDNA, Antibodies, and Cells
Full length SHARPIN, NZF (340–387) or UBL (233–314) from HeLa cDNA were
subcloned into pGEX-4T1 (GE Healthcare), pEGFP-C1 (Novagen, Madison, WI) or pBabe-
puro by standard PCR methods. Mutants of SHARPIN T358L, F359V, SHARPIN ΔNZF
(Δ350–374), SHARPIN I272A, SHARPIN ΔC (1–232), SHARPIN ΔUBL, and insertion of
6XHis-tag in C-terminus of pGEX plasmid were introduced by site-directed mutagenesis.
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pcDNA3-Myc-human HOIP, pcDNA3-HA-human HOIL-1L ΔRBR-C, pcDNA3-HA-
human HOIL-1L ΔUBL, pcDNA3-HA-human HOIL-1L ΔNZF, pGEX-6Pp1-HOIP NZF1
(aa350–379), pGEX-6P-1-HOIP NZF2 (aa 408–438), and pGEX-6P-1-HOIP NZF1+2 (aa
350–438) were described previously14. pGEX-4T1-Ubiquitin, pGEX-4T1-diUbiquitin, and
pGEX-4T1-mouse NEMO-UBAN were described elsewhere11. pMALc2x-human NEMO
was generated by a standard PCR method. pGEX-4T2-tetra-Ubiquitin was a kind gift from
Caixia Guo and Errol Friedberg. pGEX-4T1-mouse ABIN1-UBAN was described
previously12. pcDNA3-Myc-human HOIP RING mutant (C699/702S, C871/874S) and
pGEX-4T1-mouse ABIN1-UBAN D485A were generated by standard site directed
mutagenesis. pMSCV-GFP, pMSCV-Flag-DN-FADD-IRES-GFP, and pMSCV-Flag-CrmA-
IRES-GFP were kind gifts from John Silke. Anti-His (Novagen, Madison, WI), anti-
Ubiquitin (P4D1; Santa Cruz Biotechnology, Santa Cruz, CA), anti-GFP (B-2; Santa Cruz
Biotechnology), anti-HA (HA.11; Covance, Berkeley, CA), anti-Myc (9E10; Santa Cruz
Biotechnology), anti-Flag (M2, Covance), anti-Cleaved Caspase 3 (Cell Signaling), anti-
Caspase 8 (Cell Signaling), anti-Tubulin (Sigma), anti-Vinculin (Sigma), anti-PARP (Cell
Signaling), anti-p65 (Santa Cruz Biotechnology), anti-IκBα (Cell Signaling and Santa Cruz
Biotechnology), anti-pIκBα (Cell Signaling), anti-IKKα (Imgenex), anti-NEMO (Santa Cruz
Biotechnology), anti-pJNK (Cell Signaling), anti-pp38 (Cell signaling), anti-NUP62 (BD
Transduction), anti-GAPDH (Abcam), and anti-Flag M2 agarose (Sigma) were purchased
and used according to the manufacturers recommendations. Anti-HOIP and anti-HOIL-1L
were described previously14. The anti-SHARPIN antibody was raised against a fragment
representing the N-terminal region (1–162 amino acids) of human SHARPIN and affinity-
purified using the antigen affinity matrix.
Human Embryonic Kidney (HEK) 293T cells (ATCC) were maintained at 37°C, in 5% CO2
condition in DMEM (Gibco) supplemented with 10% Fetal calf serum (Gibco) and 100 U/
ml penicillin and streptomycin (Invitrogen, Carlsbad, CA). Murine TNFα, IL-1α and CD40L
were purchased from PreproTech, while LPS was from Enzo Life Sciences. zVAD-FMK
and cycloheximide were purchased from Bachem and R&D, respectively.
SILAC cells
HEK 293T cells were cultured in a custom-made SILAC-DMEM medium (lacking the
amino acids lysine and arginine, PAA). The medium was supplemented with dialysed serum
(PAA), L-Glutamine, penicillin, streptomycin and amino acids L-lysine and L-arginine. The
“light” culture was supplemented with Lys0 and Arg0 (Sigma); the “medium-heavy” culture
with Lys4 (2H4) and Arg6 (13C6); and the “heavy” culture with Lys8 (13C6 15N2) and Arg10
(13C6 15N4). All labelled amino acids were purchased from Cambridge Isotope Laboratories.
GST protein purification
Transformed E. coli were grown in LB/ampicillin at 37°C until OD = 0.3–0.5, induced with
1 mM IPTG and grown over night at 16°C. The bacteria were harvested by centrifugation
and resuspended in GST buffer (20 mMTris, pH 8.0, 100 mMNaCl) supplemented with
complete protease inhibitors (Roche Diagnostics), sonicated, and lysed in 1% Triton X-100.
The cleared lysate was incubated with Glutathione Sepharose beads (GE Healthcare) for 2
hours at 4°C with continuous rolling. The beads were subsequently washed with buffer 1
(0.1 M Tris, pH 7.8, 0.5 M NaCl), GST-buffer containing 0.35% Triton X-100 and GST
buffer alone. The purified GST-fusions were separated by SDS-PAGE and analyzed by
Coomassie staining.
GST-Pull down and Immunoprecipitation assays
HEK293T cells were transfected with the indicated constructs using FuGene6 (Roche
Diagnostics, Mannheim, Germany) or GeneJuice (Novagen) according to the manufacturer's
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protocol. Cells were treated before lysis (lysis buffer; 50 mM Hepes, 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 25 mM NaF, 10 μM ZnCl2, 10% glycerol, 1% Triton X-100,
supplemented with complete protease inhibitors (Roche)). Cleared lysates were subjected to
immunoprecipitation by incubation with the indicated antibodies, followed by Protein A/G
Agarose (Santa Cruz Biothechnology) or Protein A-agarose (Roche). Similarly, total cell
lysates were incubated with GST-proteins conjugated to Glutathione sepharose beads at 4°C.
After washing 3 times with lysis buffer, the immunoprecipitates were separated by SDS-
PAGE and analyzed by Western blot.
Purification of proteins for ITC measurements
All constructs for ITC studies have been cloned into pGEX-4T1 or pGEX-6P1 and were
expressed using E. coli BL21 as host strain. 5 to 10 L expression culture was grown to an
OD of 0.8 in LB/ampicillin media supplemented with 100 μM ZnCl2 at 37°C prior to
induction with 0.1 mM IPTG for 12 hours at 25°C. Cells were resuspended in buffer PX
(100 mM HEPES pH 7.4, 500 mM NaCl, 1 mM DTT) and lysed by sonication. The lysate
was cleared by centrifugation and loaded onto GSH Sepharose column (GE Healthcare).
Bound GST fusion protein was eluted using buffer PX containing 20 mM glutathione,
cleaved with thrombin or 3C protease, and further purified by anion exchange
chromatography using a Q Sepharose column (GE Healthcare). Fractions containing the
protein of interest were polished by size exclusion chromatography on a Superdex 75 or
Superdex 200 column (GE Healthcare). Protein concentrations were determined by UV
spectrometry at 280 nm using calculated extinction coefficients. K48 and K63-linked
ubiquitin chains were prepared essentially as described20.
Isothermal titration calorimetry
ITC measurements were performed using a VP-ITC or ITC200 (GE Healthcare). Typically
50–100 μM of SHARPIN, HOIL-1L, the isolated NZF domains and the NZF1 of HOIP were
loaded into the cell and 500–1000 μM of ubiquitin or ubiquitin chains into the syringe.
Samples were dialyzed into buffer containing 50 mM HEPES pH 7.4, 150 mM NaCl, and 1
mM TCEP. SHARPIN titrations were performed at 10° C, HOIL-1L, and HOIP titrations at
20°C. ITC data were analyzed with Origin7 (Micro Cal) supplied by the manufacturer.
Luciferase assay
HEK293T cells were plated on 48-well plates at a density of 20,000 cells/well 24 hours prior
to transfection. pNF-κB-Luc plasmid (Stratagene) and β-GAL plasmid were transfected
together with the indicated plasmids using FuGene6. After 36 hours of transfection, lysates
were prepared and subjected to luciferase assays following the manufacturer's protocol
(Roche). Internal control was measured by β-Gal activity using its substrate (Roche). All
experiments were done using quadruple samples.
In vitro ubiquitylation assay
Ubiquitin (10 μg), His-tag E1 (150 ng), UbcH7 (300 ng) (Boston Biochem), and the
indicated E3 ligase complexes (1 μg) were incubated with or without 2 mM ATP (Sigma)
for the indicated time at 37°C in ubiquitin assay buffer (20 mM Tris-HCl pH7.5, 5 mM
MgCl2, 2 mM DTT). Methylated ubiquitin was used as a negative control. To stop the
reaction, SDS-loading buffer was added and the samples were boiled at 95°C for 1 minute.
The samples were subsequently analyzed by SDS-PAGE followed by Western blotting using
a PVDF membrane.
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In vitro kinase assay
MEFs of wt, Sharpincpdm/Sharpincpdm or Sharpincpdm/Sharpincpdm HOIL-1L shRNA were
treated by TNFα (20 ng/ml) for indicated times. IKK complex was immunoprecipitated by
anti-NEMO antibody from the total cell lysates prepared from treated MEFs. Kinase assays
were performed using γ-(32P)ATP (5 μ-Ci), GST-IκBα 1–54 (1 μ-g), and the IKK complex,
incubated in the kinase buffer (25 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.1 mM sodium
orthovanadate, 5 mM β-glycerophosphate, 2 mM DTT, 20 μ-M ATP) at 30°C for 30 min.
Protein separation, digestion, and mass spectrometry
Complete protein eluates of the three pull-down experiments were combined and separated
by 1D SDS PAGE (NuPAGE 12% precast Bis/Tris gels, Invitrogen). The proteins were
visualized by staining using the Novex® Colloidal Blue Staining Kit (Invitrogen) according
to the manufacturer's instructions and the corresponding gel lane was cut into eleven pieces.
In gel trypsin digestion of the proteins was performed as described previously21.
Chloroacetamide was used for alkylation to prevent formation of lysine modifications
isobaric to Gly-Gly22. Prior to LC-MS peptides were desalted using C18 StageTips23. LC-
MS analysis was performed using a Proxeon Easy-LC system (ProxeonBiosystems) coupled
to an LTQOrbitrap XL mass spectrometer (Thermo Fisher Scientific) equipped with a
nanoelectrospray ion source (ProxeonBiosystems), as described previously24. Peptides were
eluted using a segmented gradient of 5–80% of solvent B (80% ACN in 0.5% acetic acid)
with a constant flow of 200 nl/min over 118 minutes. Full scan MS spectra were acquired in
a mass range from m/z 380 to 920 with a resolution of 60,000 in the Orbitrap mass analyzer
using the lock mass option for internal calibration25. The ten most intense ions were
sequentially isolated for CID fragmentation in the linear ion trap. Inclusion list containing
27 ions of special interest (ubiquitylated NEMO and ubiquitin peptides) was used and up to
500 precursor ion masses selected for MS/MS were dynamically excluded for 90s. Mass
spectra were processed and quantified using the MaxQuant software suite26 (version
1.0.14.3) and the data were searched using Mascot search engine (Matrix Science) against a
decoy human database (ipi.HUMAN.v3.64) containing 168,584 protein entries.
Carbamidomethylation (Cys) was defined as fixed-, and protein N-terminal acetylation,
oxidation (Met), Gly-Gly (Lys), and Gly-Gly (N-terminal) were defined as variable
modifications. Initial mass tolerance for the precursor ions was set to 7 ppm, and for the
fragment ions to 0.5 Da. The Gly-Gly (Lys) modification sites were considered localized if
the localization probability (calculated by MaxQuant software) was higher than 0.75.
Absolute quantification of ubiquitin in whole cell lysate
For absolute quantification (AQUA11) proteins were precipitated from crude cell lysates of
“light” (SHARPIN/HOIP) and “medium-heavy” (SHARPIN TF_LV/HOIP RING mutant)
SILAC-labelled HEK293T cells by chloroform/methanol precipitation. Protein
concentration was measured by Bradford before and after precipitation to determine protein
recovery. Equal amounts of protein extracts were mixed and in-solution digested by trypsin
as described previously24 and chloroacetamide was used for alkylation as described above.
Four synthetic AQUA peptides (Thermo Fisher Scientific), labelled with either Lys8 or
Arg10 on the C-terminus, were added to 100 μg of digested protein in the following
amounts: GGM(ox)QIFVK (1 pmol), TLSDYNIQK (10 pmol), ESTLHLVLR (10 pmol),
and TITLEVEPSDTIENVK (100 pmol). The peptide mixtures were further fractionated
using isoelectric focusing on an OffGel 3100 Fractionator (Agilent). Focusing was done on
13 cm (12 well) ImmobilineDryStrips pH 3–10 (GE Healthcare) at a maximum current of 50
μA for 23 kVh. Peptide fractions were collected and desalted using C18 StageTips27. LC-
MS analysis was performed as described above with the exception that full scan MS spectra
were acquired in a mass range from m/z 420 to 920. Inclusion list containing 17 ions of
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special interest (ubiquitin peptides, “light”-, “medium-heavy”- and “heavy”-labeled) was
applied and no additional masses were allowed for fragmentation. The five most intense ions
from the inclusion list were sequentially isolated for CID fragmentation in the linear ion
trap. Mass spectra were processed and searched as described above. The ESTLHLVLR
peptide was discarded from final quantitation because of an interference caused by the
overlapping isotopic distribution of another peptide. The final AQUA results are reported
per 100 μg of the crude protein extract considering the protein loss during precipitation and
substoichiometric oxidation of the GGMQIFVK peptide. The latter was estimated from the
intensities of the modified (oxidized) and unmodified forms of the GGMQIFVK peptide.
Mouse, MEF and primary cells
Sharpincpdm/Sharpincpdm mice from the C57BL/KaLawRij colony were raised in the
specific pathogen-free breeding facility at the Goethe University animal facility. Breeding
was made by crossing heterozygous female and male mice. Immortalized mouse embryonic
fibroblasts (MEFs) were established using SV40 large T-antigen transfection and serial
passaging. Mature resting primary B-cells were isolated from the spleen of 12-week old
mice of indicated genotypes by negative selection using CD43-coated magnetic beads
(Miltenyi Biotec, Bergisch Gladbach, Germany). Peritoneal macrophages were isolated by
washing the peritoneal cavity with growth media 5 days after intra-peritoneal injection of
thioglycollate. MEFs and primary cells were treated with CD40L (250 ng/ml), LPS (100 ng/
ml), TNFα (20 ng/ml) or IL-1β (1 ng/ml or 10 ng/ml) for the indicated times and subjected
to SDS-PAGE and Western blot analysis. The supernatant of macrophages was assessed for
secreted TNFα and MCP-1 by classical sandwich ELISA using ELISA kits from R&D
systems.
Immunohistochemistry
Skin tissue samples from wild type and Sharpincpdm/Sharpincpdm (male, 10 weeks after
birth) mice were fixed in Fekete's acid alcohol formalin solution and subjected to
histological analysis by H&E staining, or immunohistochemical analysis using antibodies
recognizing cleaved caspase 3, 8, and 9.
Retroviral production
pMSCV-control-GFP, pMSCV-Flag-DN-FADD IRES-GFP, and pMSCV-Flag-CrmA
IRES-GFP vectors were transfected into ecotropic phoenix cells (ATCC) using Gene Juice
(Novagen). After 36 hours of transfection, released retroviruses were filtered and used for
infection of target cells using polybrene (4 μ-g/ml). Expression of infected protein was
monitored by GFP expression.
Subcellular fractionation
To obtain nuclear and cytoplasmic fractions, cells were washed and sampled in 500 μl of
cold PBS. Pelleted cells (500 × g) were resuspended in hypotonic buffer (10 mM Tris-HCl,
pH 7.4, 10 mM sodium iodide, 5 mM MgCl2, 1 mM PMSF) and homogenized with 20
strokes in a tissue grinder. The supernatant (600 μ g) was designated the cytoplasmic
fraction. The pellet, representing the nuclear fraction, was washed with hypotonic buffer
containing 0.1% NP-40 (Calbiochem).
Apoptosis assays
Wild type, Sharpin+/Sharpincpdm or Sharpincpdm/Sharpincpdm MEFs were plated on 6-well
or 24-well plates. After 24 hours of sub-culturing, cells were treated with CHX (1 μM) or
TNFα (10 ng/ml) for the indicated times. Depending on the experimental set-up, the caspase
inhibitor zVAD-FMK (50 nM) and retroviral infection were combined. After the treatment,
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cells were harvested for SDS-PAGE followed by Western blot analysis. In parallel, a highly
sensitive, non-invasive and quantitative device, an impedance based real-time cell analyzer
(Roche), was used to study the dynamics of cell death. This device continuously monitors
the impedance to electric current flow by cells attaching on gold electrode-plated cell culture
dishes. The area covered by cells is quantified and plotted as cell index as a function of time.
10,000 to 20,000 cells were plated per well of a 96-well E-plate. 24 to 36 hours later, cells
were treated as indicated with TNFα (10 ng/ml) alone or in combination with cycloheximide
(1 μ-g/ml), followed by continuous recordings of cell index in real-time and plotted by
normalizing cell indices to one just prior to treatment of cells with the respective reagents.
Stable shRNA cell lines
Wild type or Sharpincpdm/Sharpincpdm MEFs were transduced with lentiviral particles (5
MOI) containing non-targeting (control) or HOIL-1L shRNA (sequence:
CCGGCCTACCAGATACCTGCTTCATCTCGAGATGAAGCAGGTATCTGGTAGGTT
T TTG) (Sigma). 48 hours post-transduction, cells were selected with medium containing 4
μg/ml puromycin. After two weeks, selected cells were maintained with medium containing
1 μg/ml puromycin.
Confocal fluorescence microscopy
Cells were grown on glass coverslips and treated as indicated in the figure legends. The cells
were then fixed with 2% paraformaldehyde solution (Sigma), permeabilized with 0.2%
Triton X-100 in PBS and immunostained with appropriate antibodies. Fluorophore-labeled
secondary antibodies were from Jackson Immunoresearch (West Grove, PA). DAPI was
used to stain the nuclei. The cells were mounted in Mowiol (Calbiochem, San Diego, CA)
and examined by the laser scanning confocal microscope LSM 510 META (Carl Zeiss, Jena,
Germany). Images were prepared and analyzed with the LSM Image Browser software (Carl
Zeiss).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SHARPIN is a novel component of the LUBAC complex
a, Schematic representation of the domain architecture of SHARPIN (A), HOIL-1L (B), and
HOIP (C). b, Quantitative assessment of the binding of SHARPIN, HOIL-1L, and HOIP to a
panel of ubiquitin species using isothermal titration calorimetry (ITC). The obtained
equilibrium dissociation constants of individual measurements are listed. c, Formation of a
trimeric complex between SHARPIN, HOIL-1L, and HOIP in HEK293T cells transfected
with Myc- HOIP, HA-HOIL-1L, and GFP-SHARPIN or d, in MEFs. Lysates were
immunoprecipitated and analyzed by Western blot.
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Figure 2. SHARPIN and HOIP form a novel LUBAC complex with the ability to induce linear
ubiquitylation and NF-κB activation
a, In vitro linear ubiquitin chain synthesis by purified SHARPIN and HOIP. b, Stimulation
of linear ubiquitylation by SHARPIN and HOIP in vivo. Immobilised GST-ABIN-1-UBAN
domain was used to detect linear ubiquitylation of proteins. c, MS/MS spectrum of the
prototypic linear ubiquitin peptide present in vivo. d, e, SILAC experiments comparing
relative levels of linear ubiquitin on immunoprecipitated NEMO induced by HOIP and
SHARPIN (d) or HOIP-mut (RING domain)-SHARPIN-mut( TF_LV)(Lys8,Arg10) (e). f, g,
Stimulation of NF-κB transcriptional activity by SHARPIN and HOIP in vivo. NF-κB-
luciferase assays using the indicated combinations of SHARPIN, HOIL-1L, and HOIP were
performed. Results are shown as means and s.e.m. (n=4). *P < 0.0001, determined by the
Student's t-test
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Figure 3. SHARPIN and HOIL-1L are essential for full activation of IKK and NF-κB
a, In vitro IKK-kinase activity in TNFα-treated Sharpincpdm/Sharpincpdm MEFs stably
transduced with non-targeting (control) or HOIL-1L shRNA. b, c, Defect of TNFα-induced
IκBα degradation and translocation of p65 in Sharpincpdm/Sharpincpdm MEFs stably
transduced with HOIL-1L shRNA. (n = 19–23) d, e, Impaired NF-κB activation in primary
B cells or macrophages of Sharpincpdm/Sharpincpdm stimulated with CD40L or LPS. e, f, g,
Reduced capacity of Sharpincpdm/Sharpincpdm macrophages to secrete TNFα and MCP-1 in
response to LPS. TNFα ELISA; n=5, MCP-1 ELISA; n=4. Results in c, f and g are shown as
means and s.e.m. *P < 0.0001, determined by the Student's t-test.
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Figure 4. Loss of SHARPIN sensitizes cells to FADD- and caspase-8-mediated apoptosis
a, Increased susceptibility to TNFα-induced apoptosis in SHARPIN deficient MEFs. Cell
detachment and death were measured continuously in real-time using an impedance based
real-time cell analyzer (RTCA). b, Increased caspase activation by TNFα and CHX in
SHARPIN deficient MEFs. c, d, Cell death caused by loss of SHARPIN via FADD and
caspase-8 dependent apoptotic signalling. MEFs were retrovirally transduced with indicated
proteins and treated with TNFα. e, Increased apoptotic cell death in the skin of Sharpincpdm/
Sharpincpdm mice. Normal epidermis (A) and Sharpincpdm/Sharpincpdm (B) skin samples
were immunostained for caspase-8 (C), caspase-9 (D) and caspase-3 (E). None of these
markers were present in control mouse epidermis (F). H&E; hematoxylin and eosin. Bar = 2
μm. Results in a and c are shown as means and s.e.m. (n=3).
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